播放中国国产国语纯一级黄片免费看, 大鸡吧快来啊阿啊阿啊黄片在线播放, 中文精品日韩网站在线观看视频免费, 别揉我奶头~嗯~啊~一区二区三区,AV无码播放一级毛片免费古装,亚洲春色一区二区三区,91大神极品,美国一级大黄一片免费下载,午夜爽爽爽男女免费观看软件

Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-BROMO-4-ISOPROPYLANILINE, also known as 2-Bromo-4-(1-methylethyl)aniline, is an organic compound with the molecular formula C9H12BrN. It is a derivative of aniline, featuring a bromine atom at the 2nd position and an isopropyl group at the 4th position. 2-BROMO-4-ISOPROPYLANILINE is characterized by its potential reactivity and structural diversity, making it a valuable intermediate in the synthesis of various pharmaceutical compounds.

51605-97-1

Post Buying Request

51605-97-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

51605-97-1 Usage

Uses

Used in Pharmaceutical Industry:
2-BROMO-4-ISOPROPYLANILINE is used as a key intermediate in the synthesis of various pharmaceutical compounds, specifically for the preparation of 4-(5-aryl-1, 2, 3, 6-tetrahydropyridino) pyrimidine derivatives and 4-substituted-2-anilinopyrimidine derivatives. These derivatives are known to exhibit significant biological activities and are particularly useful as corticotropin-releasing factor (CRF) antagonists.
CRF antagonists are a class of drugs that block the action of corticotropin-releasing factor, a neuropeptide involved in the stress response and the regulation of various physiological processes. By inhibiting the effects of CRF, these antagonists can potentially be used to treat a range of conditions, including anxiety, depression, and certain neurological disorders.

Check Digit Verification of cas no

The CAS Registry Mumber 51605-97-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,6,0 and 5 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 51605-97:
(7*5)+(6*1)+(5*6)+(4*0)+(3*5)+(2*9)+(1*7)=111
111 % 10 = 1
So 51605-97-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H12BrN/c1-6(2)7-3-4-9(11)8(10)5-7/h3-6H,11H2,1-2H3

51605-97-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (A14995)  2-Bromo-4-isopropylaniline, 97%   

  • 51605-97-1

  • 5g

  • 681.0CNY

  • Detail
  • Alfa Aesar

  • (A14995)  2-Bromo-4-isopropylaniline, 97%   

  • 51605-97-1

  • 25g

  • 1515.0CNY

  • Detail
  • Alfa Aesar

  • (A14995)  2-Bromo-4-isopropylaniline, 97%   

  • 51605-97-1

  • 100g

  • 5299.0CNY

  • Detail

51605-97-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Bromo-4-isopropylaniline

1.2 Other means of identification

Product number -
Other names 2-BROMO-4-ISOPROPYLANILINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:51605-97-1 SDS

51605-97-1Relevant articles and documents

Novel phenylcarbazole type organic compounds and an organic electroluminescent device comprising the same

-

Paragraph 0249-0252, (2021/06/09)

An organic compound represented by chemical formula 1 and an organic light emitting device including the same are provided. Chemical Formula 1.

Environmentally benign indole-catalyzed position-selective halogenation of thioarenes and other aromatics

Shi, Yao,Ke, Zhihai,Yeung, Ying-Yeung

supporting information, p. 4448 - 4452 (2018/10/17)

Halogenated aromatic compounds are the cores of many pharmaceutical, agricultural and chemical products but they are commonly prepared using electrophilic halogenation reactions in non-green chlorinated solvents under harsh conditions. A separate problem happens in the aromatic halogenation of thioarenes because they readily undergo oxidative side-reactions. Herein we report an environmentally benign electrophilic bromination of aromatics using an indole-catalytic protocol, which is suitable for a wide range of substrates including thioarenes.

INDANYL COMPOUNDS AS VOLTAGE GATED SODIUM CHANNEL MODULATORS

-

Page/Page column 63, (2018/09/28)

The invention relates to indanyl compounds, their pharmaceutically acceptable salts thereof, processes for their preparation and pharmaceutical compositions comprising the same for the treatment, management and /or lessening severity of diseases, disorders, syndromes or conditions which are associated with the voltage-gated sodium channels (VGSC). More specifically the present invention provides compounds having the structure of Formula (I).

Copper-Catalyzed Enantioselective Conjugate Addition to α,β-Unsaturated Aldehydes with Various Organometallic Reagents

Goncalves-Contal, Sylvie,Gremaud, Ludovic,Palais, La?titia,Babel, Lucille,Alexakis, Alexandre

, p. 3301 - 3308 (2016/09/12)

β-Substituted aldehydes constitute a very important class of compounds found in nature. Synthesis of this motif can be envisioned by C-C bond formation on enals. For this purpose, we report herein the development of enantioselective copper-catalyzed conjugate addition of various organometallic reagents to α,β-unsaturated aldehydes with (R)-H8BINAP, (R)-TolBINAP, and (R)-SEGPHOS as chiral ligands. Three sets of conditions were successfully developed and several enals were used. Reactivity and regio- and enantioselectivities were strongly dependent on reaction conditions and substrates. Good to excellent regio- and enantioselectivities were obtained with zinc reagents R2Zn and aluminum reagents R3Al. However, the asymmetric conjugate addition of Grignard reagents afforded only moderate to good regio- and enantioselectivities.

Design, synthesis, and biological evaluation of novel transrepression- selective liver X receptor (LXR) ligands with 5,11-dihydro-5-methyl-11- methylene-6 H-dibenz[ b, e ]azepin-6-one skeleton

Aoyama, Atsushi,Endo-Umeda, Kaori,Kishida, Kenji,Ohgane, Kenji,Noguchi-Yachide, Tomomi,Aoyama, Hiroshi,Ishikawa, Minoru,Miyachi, Hiroyuki,Makishima, Makoto,Hashimoto, Yuichi

, p. 7360 - 7377 (2012/11/07)

To obtain novel transrepression-selective liver X receptor (LXR) ligands, we adopted a strategy of reducing the transactivational agonistic activity of the 5,11-dihydro-5-methyl-11-methylene-6H-dibenz[b,e]azepin-6-one derivative 10, which exhibits LXR-mediated transrepressional and transactivational activity. Structural modification of 10 based on the reported X-ray crystal structure of the LXR ligand-binding domain led to a series of compounds, of which almost all exhibited transrepressional activity at 1 or 10 μM but showed no transactivational activity even at 30 μM. Among the compounds obtained, 18 and 22 were confirmed to have LXR-dependent transrepressional activity by using peritoneal macrophages from wild-type and LXR-null mice. A newly developed fluorescence polarization assay indicated that they bind directly to LXRα. Next, further structural modification was performed with the guidance of docking simulations with LXRα, focusing on enhancing the binding of the ligands with LXRα through the introduction of substituents or heteroatom(s). Among the compounds synthesized, compound 48, bearing a hydroxyl group, showed potent, selective, and dose-dependent transrepressional activity.

Enantioselective copper-catalyzed conjugate addition of trimethylaluminium to β,γ-unsaturated α-ketoesters

Gremaud, Ludovic,Alexakis, Alexandre

supporting information; experimental part, p. 794 - 797 (2012/03/09)

Not a cop out: The copper-catalyzed asymmetric conjugate addition of organometallic reagents to Michael acceptors is an important methodology for forming a C-C bond in an enantioselective manner. Such an addition of Me 3Al to β,γ-unsaturated α-

HETEROTRICYCLIC METALLOPROTEASE INHIBITORS

-

Page/Page column 63, (2008/12/05)

The present invention relates generally to azatricyclic containing pharmaceutical agents, and in particular, to azatricyclic metalloprotease inhibiting compounds. More particularly, the present invention provides a new class of azatricyclic MMP-3, MMP-8 a

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 51605-97-1